HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637HAD1. A total of 64 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $17,880,122 | -5.7% | 21,190,000 | -7.2% | 0.01% | +8.3% |
Q2 2023 | $18,961,913 | +9.1% | 22,830,000 | +11.4% | 0.01% | 0.0% |
Q1 2023 | $17,373,955 | -11.0% | 20,500,000 | +1.7% | 0.01% | -25.0% |
Q4 2022 | $19,522,341 | +12.4% | 20,165,000 | -1.7% | 0.02% | +33.3% |
Q3 2022 | $17,362,000 | -6.6% | 20,516,000 | -2.7% | 0.01% | -14.3% |
Q2 2022 | $18,597,000 | +166.8% | 21,081,000 | +163.5% | 0.01% | +250.0% |
Q1 2022 | $6,970,000 | – | 8,000,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wellesley Asset Management | 71,432 | $63,617,000 | 4.32% |
Western Asset Management Company, LLC | 15,600,000 | $13,690,000 | 4.04% |
CAMDEN ASSET MANAGEMENT L P /CA | 70,849,000 | $61,727,000 | 1.84% |
ZAZOVE ASSOCIATES LLC | 16,992,000 | $14,985,000 | 1.32% |
Penn Mutual Asset Management, LLC | 1,305,000 | $1,137,000 | 1.32% |
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 64,750,000 | $56,413,000 | 0.72% |
CQS (US), LLC | 10,000,000 | $8,777,000 | 0.61% |
ADVENT CAPITAL MANAGEMENT /DE/ | 28,859,000 | $25,319,000 | 0.40% |
Context Capital Management, LLC | 4,122 | $3,632,000 | 0.24% |
Hudson Bay Capital Management LP | 19,500,000 | $17,152,000 | 0.23% |